Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

An optimization framework for hierarchical clustering.

Bioinformatics advances·2026

Same author

Toward identification of common DNA repair process in mutational signatures.

bioRxiv : the preprint server for biology·2026

Same author

Signing protein-protein interaction networks.

Bioinformatics (Oxford, England)·2025

Same author

Unifying proteomic technologies with ProteinProjector.

Bioinformatics advances·2025

Same author

Integrated spatial proteomic analysis of breast cancer heterogeneity unravels cancer cell phenotypic plasticity.

Nature communications·2025

Same author

An adversarial scheme for integrating multi-modal data on protein function.

Cell systems·2025

Search research articles

Related Experiment Video

Updated: Dec 2, 2025

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

Prediction of cancer dependencies from expression data using deep learning.

Nitay Itzhacky¹, Roded Sharan

¹School of Computer Science, Tel Aviv University, Tel Aviv 69978, Israel. roded@tauex.tau.ac.il.

Molecular Omics

|November 2, 2020

Summary

This study introduces new deep learning models to predict cancer gene dependencies and drug sensitivities from gene expression data. These models can identify tumor vulnerabilities and suggest potential drug targets for cancer treatment.

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

Related Experiment Videos

Last Updated: Dec 2, 2025

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

Area of Science:

Computational Biology
Genomics
Machine Learning

Background:

Identifying cancer dependencies is crucial for developing effective treatments.
Previous research mapped gene dependencies and drug sensitivities across numerous cancer cell lines.
These datasets enable the creation of models for tumor vulnerability and novel drug target discovery.

Purpose of the Study:

To develop novel deep learning methods for predicting gene dependencies and drug sensitivities.
To leverage gene expression data for identifying potential cancer therapeutic targets.

Main Methods:

Utilized deep learning techniques for predictive modeling.
Combined dimensionality reduction strategies with neural networks.
Analyzed gene expression measurements from cancer cell lines.

Main Results:

Developed accurate models for predicting gene dependencies and drug sensitivities.
Demonstrated superior performance compared to traditional neural networks and linear models.
Successfully learned models of tumor vulnerabilities.

Conclusions:

Novel deep learning approaches can effectively predict cancer gene dependencies and drug sensitivities.
The developed models offer a powerful tool for identifying novel drug targets.
This work advances the application of machine learning in precision oncology.